Suchergebnisse - "Guven, Deniz Can"

PubPharm (176)

1

Datopotamab deruxtecan : A novel antibody drug conjugate for triple-negative breast cancer

enthalten in: Heliyon | 2024

von Schipilliti, F. | Drittone, D. | Mazzuca, F. | +3

2

Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy

enthalten in: International journal of clinical oncology | 2024

von Sahin, T. | Ozbay, Y. | Altunbulak, A. | +6

3

Unveiling cancer risk in ANCA-associated vasculitis : result from the Turkish Vasculitis Study Group (TRVaS)

enthalten in: Internal and emergency medicine | 2024

von Bilgin, E. | Demirci Yıldırım, T. | Özdemir Ulusoy, B. | +36

4

Sirolimus experience in adult patients with vascular malformations

enthalten in: Vascular | 2024

von Akyildiz, A. | Ismayilov, R. | Guven, D. | +8

5

The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors : a systematic review and meta-analysis

enthalten in: Breast cancer research and treatment | 2024

von Guven, D. | Sahin, T.

6

Immunotherapy use in older adults with cancer with frailty : A young SIOG review paper

enthalten in: Journal of geriatric oncology | 2024

von Guven, D. | Martinez-Cannon, B. | Testa, G. | +4

7

Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab

enthalten in: Biomolecules & biomedicine | 2024

von Yildirim, H. | Anik, H. | Ozdemir, D. | +9

8

Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy

enthalten in: Cancers | 2024

von Güner, G. | Özçakar, L. | Baytar, Y. | +11

9

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients : a Turkish oncology group (TOG) study

enthalten in: International journal of clinical oncology | 2024

von Yıldırım, H. | Kutlu, Y. | Mutlu, E. | +31

10

Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer

enthalten in: Future oncology (London, England) | 2024

von Karacin, C. | Sunar, V. | Urakci, Z. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]